Keywords: purging; cytogenetics; CFU-GM; LTCIC; FISH Although the mobilization and harvesting of Philadelphia chromosome-negative progenitors has been proven feasible by a number of groups, it is not clear which Chronic myeloid leukemia (CML) originates in a hematotechniques should be used with regard to the monitoring poietic stem cell which undergoes a reciprocal translocation of purging and evaluation of stem cell yield. Therefore, between chromosomes 9 and 22. The resulting Philadelphia we isolated CD34-positive cells from leukapheresis chromosome (Ph) 1 is characterized by the fusion of the bcr samples of seven CML patients after induction therapy.
PCR. We compared these results with the cytogenetic
The rationale for autografting resides in the knowledge analysis of the leukapheresis material. Molecular analythat nonclonal 8 Ph-negative hematopoietic progenitors sis of individual colonies correlated well with the results reside in the bone marrow of CML patients.
9,10
of cytogenetic analysis. However, in nine out of 18 Compilation of the results from eight transplant groups samples, cytogenetic analysis exclusively demonstrated encompassing 200 patients, indicate a plateau in the surthe presence of either Philadelphia chromosome-posivival curve for patients treated with an autograft. 11 Howtive or -negative cells whereas with the molecular analyever, it should be kept in mind that results concerning autosis of individual colonies tumor contamination or the grafting in CML are single arm studies with selected patient presence of residual normal cells could be substantiated.
groups.
12-14
We concluded that molecular analysis of individual col-A drawback of autografting is the reinfusion of maligonies should be employed to further optimize induction nant cells which can result in the re-emergence of the CML.
protocols. With regard to stem cell mobilization we
It has been demonstrated that the percentage of reinfused demonstrated that about 67 CFU-GM colonies and clusmalignant cells correlates with the number of Ph-positive ters were generated by one single LTCIC both for the metaphases post-transplant. 15 Moreover, marking studies as CML samples and the samples obtained from patients pioneered by Brenner et al, 16, 17 have demonstrated that with non-hematologic malignancy. This number is relapse after autologous bone marrow transplantation is at important since until now most centres use a number least partly caused by the reinfused malignant cells. 18 For of four colonies and clusters generated by one LTCIC.
acute myeloid leukemia purged grafts can result in a sigDividing the CFU-GM output in the LTCIC assay by nificantly lower relapse rate as compared to unpurged four to determine LTCIC frequency could thus lead to grafts. 19 These results indicate that it could be important to an almost 20-fold overestimation of the LTCIC freeliminate malignant progenitors from the autograft.
quency. It is concluded that stem cell frequency analysis
In vivo purging aims at the reduction and hopefully the is an important tool with regard to the interpretation elimination of the leukemic clone after which normal stem of mobilization protocols.
cells can be harvested and used for autografting. The mobilization of Ph-negative stem cells in CML has been pioneered by Carella et al. 20 They used intensive chemotherapy kapheresis has proven feasible. 22 Several groups have 8, G-CSF 5 g/kg per day subcutaneously starting at day 8. From patient 6 stem cells were harvested via leukapherattempted to reproduce these results and improve on mobilization protocols. [23] [24] [25] [26] [27] However, residual tumor cells could esis after this first cycle. The second course B II consisted of Ara-C 2 × 1000 mg/m 2 by continuous infusion over 24 h often be detected.
The golden standard to determine tumor contamination daily for 5 days, amsacrine 120 mg/m 2 for 30 min daily from days 1 to 3, G-CSF 5 g/kg per day subcutaneously is cytogenetic analysis, where actively dividing cells are analyzed for the presence of the Philadelphia chromosome.
starting at day 8. Collection of peripheral blood progenitor cells started as soon as more than 0.5 × 10 9 neutrophils/l However, as a result of treatment dividing cells are often scarce 28 and to what extent the actively dividing cells conwere present in the blood. Leukapheresis was performed with a Baxter CS 3000 machine (Baxter, Utrecht, The tribute to post-transplant recovery is unclear. 29 Apart from the problem of what kind of cells are reinNetherlands). Harvested cells were cryopreserved using a controlled rate freezer. Seven patients were enrolled in the fused is the problem of how many stem cells are reinfused. Stem cell frequency analysis can only be performed proptwo mobilization regimens (patient characteristics are listed in Table 1 ). erly using primitive progenitor assays at limiting dilution. Sutherland et al 30 demonstrated, using the LTCIC asay at limiting dilution, that on average four CFU-GM colonies Cell processing and progenitor assays and clusters are generated by one single LTCIC. Several groups have made use of this number dividing bulk LTCIC Samples obtained from the leukapheresis sessions from each patient were pooled. Mononuclear cells were isolated cultures by a factor four to determine the stem cell frequency. 30 However, variability in CFU-GM output per from the samples by Ficoll-Paque (Pharmacia, Uppsala, Sweden) density gradient centrifugation (␦ = 1.077 g/cm 3 ). LTCIC could lead to an under-/overestimation of the LTCIC frequency.
Remaining red cells were lysed with ammonium-chloride. CD34-positive cells were isolated using the MiniMacs sysThis paper deals with in vivo purging and we addressed the question of what techniques should be used to analyze tem (Miltenyi Biotec, Bergisch Gladbach, Germany) according to the instructions of the manufacturer. After two a harvest with respect to stem cell content and purging efficiency. We analyzed CD34-positive cells, isolated from consecutive passages over two separation columns, purity was always more than 90% as determined by FACS analyleukapheresis samples of seven patients with CML treated with chemotherapy and G-CSF, in the CFU-GM and sis. One sample (patient 2 after induction) was analyzed for CFU-GM content after cryopreservation and thawing. LTCIC assays to evaluate differential response of committed and uncommitted progenitors. LTCIC frequency and Additional experiments (data not shown) on four fresh and cryopreserved samples showed that no selective loss of bcr-CFU-GM output per single LTCIC was determined using the LTCIC assay at limiting dilution. Individual colonies abl-positive or -negative progenitors occurred. CFU-GM: CD34-positive cells were cultured in semiderived from both the CFU-GM and LTCIC assays were analyzed for the presence of the bcr-abl gene or the solid medium in the presence of 5% human placentaconditioned medium (HPCM). 31 Cultures were incubated at derivative mRNA. We compared these results with the cytogenetic metaphase analysis of the unprocessed 37°C in 5% CO 2 . The cells were plated at four different concentrations: 500, 1000, 5000 and 10 000 CD34-positive leukapheresis material. cells per ml CFU-GM medium, in triplicate to optimize colony density for quantification and colony harvesting. Colonies (Ͼ40 cells) and clusters (8-40 cells) were counted Materials and methods at day 12 and colonies were plucked at random from different cultures with a vacuum capillary system. The colony Patients and regimens size was about 500 cells. LTCIC: 30 In order to obtain feeder layers, human bone Patients aged less than 60 years who were in first chronic phase were eligible for this study if no HLA compatible marrow cultures were initiated with samples obtained from healthy volunteers in LTBMC medium: 9 alfa medium supdonor was available. Patients received two types of induction chemotherapy. The first (A) consisted of Ara-C plemented with 12.5% horse serum, 12.5% fetal calf serum, 10 −4 m ␤-mercaptoethanol, 10 −6 m hydrocortisone sodium 200 mg/m 2 by continuous infusion over 24 h daily for 7 days, daunorubicin 30 mg/m 2 for 30 min daily from days 1 succinate, glutamine, penicillin and streptomycin. After 2 weeks of culturing the adherent stromal cell layer was harto 3, granulocyte colony-stimulating factor (G-CSF, filgrastim: Amgen, Breda, The Netherlands) 5 g/kg per day vested using trypsin (all from Gibco, Grand Island, NY, USA), irradiated with 13 Gy ( 60 Co) and plated in 96-well subcutaneously starting at day 8. Collection of peripheral blood progenitor cells started when more than 5000 CD34-plates (Costar, Cambridge, MA, USA) at 1.25 × 10 4 cells in 200 l LTBMC medium. Alternatively, the irradiated positive cells/ml or more than 0.1 × 10 9 neutrophils/l were present in the blood. The second regimen, B, was an intenmurine M210-B4 cell line was used as a stromal feeder layer. 32 After 2-7 days CD34-positive cells, derived from sification of regimen A since evaluation of the first three patients showed only a moderate chemotherapeutic supthe CML patients, were plated on top of the stromal cell layer and underwent a weekly half medium change. Culpression of hematopoiesis. It consisted of two chemotherapy courses, B I and B
II
. Course B I consisted of Ara-C tures were incubated at 37°C in 5% CO 2 . After 5 weeks, both the nonadherent and adherent cells (using trypsin) 200 mg/m 2 by continuous infusion over 24 h daily for 7 days, idarubicin 12 mg/m 2 for 30 min daily from days 6 to were harvested and the CFU-GM capacity of cells was 837 determined as described above. The linearity between input hybridization at 37°C the cells were washed at 40°C with 55% formamide in 2 × SSC, followed by 0.1 × SSC at CD34-positive cells and CFU-GM output of LTCICs was determined: long-term cultures initiated with different con-60°C. The biotin-labeled probe was detected with fluorescein avidin DN (Vector Laboratories, Burlingame, CA, centrations of CD34-positive cells (ranging from 1000 to 20 000 per well) were harvested and plated in the CFU-GM USA) followed by biotinylated anti-avidin (Vector Laboratories) and fluorescein avidin DN (Vector assay, each at three different concentrations in triplicate. In addition for some samples, the frequency of the LTCICs Laboratories). The digoxigenin-labeled probe was detected with anti-digoxigenin-rhodamin (Boehringer Mannheim) (number of LTCICs per CD34-positive cell) was determined with the limiting dilution assay. CD34-positive cells followed by Texas red-conjugated donkey anti-sheep (Jackson Immunoresearch, West Grove, PA, USA). After were plated at concentrations of 50, 150, 500 and 1000 cells per well using 24 wells per concentration. After culturing dehydration slides were embedded using Vectashield (Vector Laboratories) containing 0.1 g/ml Dapi (Sigma). for 5 weeks the cells were plated in the CFU-GM assay. Cultures were scored positive when CFU-GM capacity Samples were scored with an Axioskop 50 (Carl Zeiss Jena, Jena, Germany) using a triple band pass filter (Omega could be determined. The LTCIC frequencies were determined with Poisson statistics. 30 Combination of LTCICOptical, Brattleboro, VT, USA). Nuclei were scored positive for the bcr-abl gene when a green and a red spot were derived CFU-GM output per CD34-positive cell in the LTCIC assay with the frequency of LTCIC per CD34-posiless than one spot diameter apart. A colony was scored when at least 10 nuclei could be evaluated. More than 90% tive cell leads to the CFU-GM output/single LTCIC: (LTCIC-derived CFU-GM output/CD34 + cell)/ of the evaluable nuclei of a single colony needed to generate the same (+ or −) result, otherwise a colony was con-(LTCIC/CD34 + cell) = (CFU-GM output/single LTCIC). sidered not evaluable. About 100 nuclei per colony were evaluable.
Molecular analysis
RT-PCR was performed as described before. 33 Briefly, cells derived from a single colony were dissolved in GTCInterphase-FISH (I-FISH) was performed as described before. 33 Briefly, cells derived from a single colony were buffer. Total RNA was isolated using the acid guanidiniumphenol-chloroform (AGPC) method. 36 Twenty micrograms put on to a glass slide, fixed in 70% ethanol and dipped in a 0.1% gelatine (Sigma, St Louis, MO, USA) solution 34 glycogen (Boehringer Mannheim) were used as carrier during precipitations. After annealing of the anti-sense primer, incubated with 0.1 mg/ml RNAse A (Boehringer Mannheim, Mannheim, Germany) followed by 0.01% pepcDNA was synthesized and amplified in a nested PCR. The PCR products were size fractionated on a 2% agarose gel sin (Sigma). After postfixation the slides were dehydrated and denatured at 72°C in 70% formamide (Baker, Deventer, and transferred to a nylon membrane (Genescreenplus; DuPont, Boston, MA, USA). The specificity of the ampliThe Netherlands). Cosmids bcr 51 and abl 18 (a kind gift from Dr G Grosveld and Dr A Hagemeijer, Erasmus Unimers was determined after hybridization with 32 P-labeled internal oligonucleotide 9: (5′-GGGGTCATTTTCversity, Rotterdam, The Netherlands) were labeled by nicktranslation with digoxigenin-11-dUTP (Boehringer ACTGGGTCCAGCGAGAAGGT-3′) followed by autoradiography. The abl gene is ubiquitously expressed and Mannheim) and biotin-14-dATP (Gibco), respectively. 35 Fifteen nanograms of each probe were mixed with a 100-the abl RT-PCR serves as a control for quality of the RNA isolation, cDNA synthesis and PCR amplification. All prifold excess of Hu-cot-1 DNA (Gibco) in 50% formamide, 2 × SSC and 10% dextran-sulphate (Sigma). This solution mers pairs were positioned across intron exon borders so that amplification of genomic sequences could be diswas denatured at 74°C for 4 min, cooled on ice and incubated at 37°C for 2 h and subsequently layered on to the tinguished by size. 37 Strict measures were taken to avoid contamination. All experiments included water blanks as slides and sealed with rubber cement. After an overnight negative controls. The Ph-positive K562 cell line was used Mobilization of hematopoietic progenitors as a positive control. In each experiment a serial dilution
The efficiency of mobilization was monitored in the harvest of K562 cDNA was included to assess the sensitivity of by determination of: (1) the number of CD34-positive cells the RT-PCR and the relative sensitivity of the bcr-abl and present and (2) the number of CFU-GM/CD34-positive abl RT-PCRs.
cells and the number of LTCIC-derived CFU-GM colonies/CD34-positive cell (see Table 3 ). CD34-positive Cytogenetics cells were also plated at limiting dilution in the LTCIC assay to determine the LTCIC frequency. The combination A sample of the harvest was cultured for 2 days in 10% of the number of LTCIC per CD34-positive cell as determ-FCS RPMI in the presence of 10 mm colcemid. Cells were ined with the LTCIC assay at limiting dilution, with the fixed in methanol/acetic acid until use. Metaphase spreads LTCIC-derived CFU-GM output per CD34-positive cell as were stained using standard G-banding techniques.
determined with the LTCIC assay, generates the number of CFU-GM colonies and clusters generated per single LTCIC.
Results
After mobilization of patients 1, 2 and 3 on average 4.2 × 10 8 CD34-positive cells could be harvested after two Seven patients were studied (patient characteristics are or in one case even after one leukapheresis session. One listed in Table 1 ). Cytogenetic analysis showed that six hundred CD34-positive cells on average gave rise to five patients were positive for the Philadelphia chromosome.
colonies/clusters in the CFU-GM assay and generated a One patient (patient 6) had a variant translocation CFU-GM output of 10 colonies/clusters in the LTCIC t(9;15;22) involving chromosomes 9, 22 and 15, and with assay. Patients 4, 5 and 6 were further treated with the RT-PCR the presence of the bcr-abl mRNA could be second induction course whereby on average 2.4 × 10 8 detected. Patient 3 showed loss of the Y chromosome, in CD34-positive cells could be harvested. Overall, for addition to the Philadelphia chromosome, in all metaphases analyzed.
Table 3
Mobilization of hematopoietic progenitors and was therefore not treated further. a Time in days to reach more than 0.1 × 10 9 neutrophils/l blood. b Time in days to reach more than 0.5 × 10 9 neutrophils/l blood. c Time in days to reach more than 50 × 10 9 platelets/l blood. patients 4-7, 100 CD34-positive cells generated a mean 21 interphase FISH. In a previous study, we analyzed 160 colonies pairwise with both RT-PCR and FISH. 33 These colonies/clusters in the CFU-GM assay and generated a mean CFU-GM output of 54 colonies/clusters in the LTCIC results indicated that all FISH-positive colonies harbored detectable amounts of bcr-abl mRNA although often assay. Thus, induction with regimen A resulted in a higher yield of CD34-positive cells but these cells had a lower repeated RT-PCR analysis was necessary. In the present study nine colonies were analyzed both with FISH and RT-CFU-GM and LTCIC capacity as compared to the CD34-positive cells from regimen B.
Hematologic recovery after chemotherapy
PCR. Four were negative both with FISH and RT-PCR, three were positive with both techniques, and two colonies CD34-positive cells obtained from seven leukapheresis samples were plated at limiting dilution in the LTCIC assay were positive with FISH but negative with RT-PCR. In agreement with our previous study, RT-PCR was positive to determine the absolute number of stem cells (see Table 4A ). On average, one in every 152 CD34-positive after repeated analysis of the cDNA of these two colonies. Thus, all further experiments were performed using FISH cells was a LTCIC. No large differences between the different mobilization schemes (A, B I and B II ) were evident. The analysis only. FISH analysis was performed on 691 colonies in total. frequency analysis combined with the CFU-GM output per CD34-positive cell in the LTCIC assay indicated a mean Patients 1, 2 and 4 showed 80, 59 and 59% bcr-abl-negative CFU-GM colonies, respectively, and 55, 56 and 60% CFU-GM output per single LTCIC of 67 colonies/clusters. This finding has been verified using four samples of differbcr-abl-negative LTCIC-derived colonies, respectively (see Table 5 ). Analysis of patient 7 revealed that all 14 CFUent origin (see Table 4B ): a sample from a chronic phase CML patient at diagnosis and three leukapheresis samples GM colonies examined were bcr-abl positive. However, three out of seven of the LTCIC-derived colonies were bcrobtained from patients with non-hematologic malignancy after stem cell mobilization. Again the output was relatively abl negative. Patients 3, 5 and 6 showed only bcr-abl-positive CFU-GM and LTCIC colonies, except for each one high: 47 for the CML sample and on average 70 colonies/clusters per single LTCIC for the leukapheresis bcr-abl-negative CFU-GM or LTCIC colony after induction. Remarkably, the three patients with the highest purgsamples.
ing effect (patients 1, 2 and 4) also showed the lowest leukocyte counts at diagnosis ( ) cytogenetics number of Ph-positive and -negative cells. In parallel, individual CFU-GM and LTCIC colonies were analyzed with failed, where colony analysis was possible and found to be Number of LTCIC-derived CFU-GM colonies/clusters generated per CD34-positive cell. c LTCIC frequency expressed as number CD34-positive cells giving rise to one LTCIC. Number of CFU-GM colonies/clusters generated by one LTCIC. e LF, leukapheresis samples obtained from patients with non-hematologic malignancy after stem cell mobilization.
f Unique patient number of a CML patient at diagnosis. Table 5 Molecular analysis of the mobilized CFU-GM and LTCIC colonies 100% positive. Furthermore, in three cases cytogenetics etics correlates well with molecular analysis of colonies: seven cases were 100% positive with cytogenetics and colwas 100% Ph positive whereas bcr-abl-negative colonies could be detected (patient 1, preinduction, patient 6, regiony analysis and in two cases a mixture of bcr-abl-positive and -negative cells was detected both with colony analysis men B II and patient 7, regimen B I ). These discrepancies between colony analysis by FISH and cytogenetics and cytogenetics. The second group consists of five samples, either 100% positive or 100% negative with cytoprompted us to make a more thorough comparison. In total, 18 samples including the 10 samples depicted in Table 5 , genetics but containing a mixture of bcr-abl-positive andnegative colonies using FISH analysis. The third group conwere analyzed with both techniques (see Table 6 ). Three groups could be distinguished. In the first group, cytogensists of four samples where cytogenetic analysis failed: two (n = 12) and 188 for leukapheresis samples (n = 36). Interestingly, no difference could be detected between Mobilization of Ph-negative hematopoietic progenitor cells to the blood has been proven feasible by a number of the CML-derived samples and the samples derived from the control patients, indicating that the purging measured groups. 8, 20, 23, 24, 38, 39 We analyzed samples obtained from seven CML patients treated with induction therapy.
is not the result of an increased clonogenecity per normal LTCIC but probably reflects a true decline of Ph-positive Three out of seven patients (patients 1, 2 and 4) had a more than 50% purged harvest as determined with the LTCIC frequency as compared to the normal LTCIC frequency. Taken together, these results underline the impormolecular analysis of CFU-GM and LTCIC-derived colonies. None of the patients showed evidence of a 100% tance of combining stem cell frequency analysis with the analysis of the LTCIC-derived CFU-GM output for the purged harvest. However, we were able to detect bcr-ablnegative CFU-GM and/or LTCIC activity in six of the assessment of the quality of stem cell harvest.
We concluded that molecular analysis of individual colseven patients.
Cytogenetic analysis correlated well with the analysis of onies is an important tool for the monitoring of purging efficacy and should be used in future efforts to evaluate individual colonies (Table 6 ). However, in nine out of 18 samples, colony analysis added important information mobilization procedures. We demonstrated that about 67 CFU-GM colonies and clusters were generated by one sinabout the content of the harvest. Moreover, cytogenetic analysis failed in some cases, especially in difficult mobilizgle LTCIC both for CML and controls. Dividing the CFU-GM output in the LTCIC assay by four to determine LTCIC ations with a low percentage of CD34-positive cells, or when samples were analyzed after cryopreservation. Colfrequency could thus lead to a more than 20-fold overestimation of the real LTCIC frequency. It is concluded that stem ony analysis on the other hand proved to be possible in every case. Coulombel et al 9 demonstrated the presence of cell frequency analysis is an important tool with regard to mobilization protocols. Ph-negative LTCIC-derived colonies and CFU-GM colonies in bone marrow samples of which the direct preparation was 100% Ph positive. These data, combined with our results, demonstrate that cytogenetic analysis of the unproReferences cessed material is not sufficient for evaluating purging efficiency. GM colonies and clusters generated by one single LTCIC. 
